DDMAC warning and untitled letters in 2008 total 21

Share this article:

The FDA's Division of Drug Marketing, Advertising and Communications issued 21 warning and untitled letters in 2008 – scarcely more than the 20 letters the unit sent out in 2007.

As in 2007, 10 were “warning letters,” the remainder being of the somewhat less serious “untitled” variety.

In 2006, DDMAC issued 22 letters reprimanding drug manufacturers for promotional materials deemed violative of the Food, Drug and Cosmetics Act, typically for overstating efficacy and/or underplaying risks, but 14 of those were warning letters.

Share this article:

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.